Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Search

Top

INO THERAPEUTICS LLC Hazelwood MO 63042 USA

UEI: SLED_6F02F6F7B638F4DC

INO THERAPEUTICS LLC Hazelwood MO 63042 USA is a federal contractor, registered under UEI SLED_6F02F6F7B638F4DC. It has been awarded $732,512 across 1 federal contract. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Defense Health Agency.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_6F02F6F7B638F4DC

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Defense Health Agency$732.5K100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$732.5K100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with INO THERAPEUTICS LLC Hazelwood MO 63042 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for INO THERAPEUTICS LLC Hazelwood MO 63042 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in INO THERAPEUTICS LLC Hazelwood MO 63042 USA's top NAICS codes and agencies

Latanoprost Ophthalmic Solution ManufacturingThis subcontract involves the manufacturing of Latanoprost Ophthalmic Solution to support prime contractors on pharmaceutical procurement projects for the Department of Veterans Affairs. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and sterile filling into ocular medication containers. All operations must be conducted within cleanrooms using pharmaceutical-grade API and in strict adherence to current Good Manufacturing Practices. To ensure safety and standardization, the manufacturer must follow the American Academy of Ophthalmology’s uniform color-coding system for all labels and caps. The final deliverable consists of finished, labeled, and packaged solutions assigned a unique NDC number. This project is categorized under NAICS code 325412 and is managed through Nac Pharmaceuticals.

Nac Pharmaceuticals (36E797)

POSTED

about 20 hours ago

DEADLINE

Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract

Solicitation # HT942627RE002

Defense Health Agency

POSTED

about 20 hours ago

DEADLINE

Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract

Solicitation # HT942626RE002

The Defense Health Agency Contracting Activity is issuing a pre-solicitation notice for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. This initiative aims to expand the pool of eligible contractors providing military medical research and development services, including laboratory and technical support, regulatory process expertise, and translational science services. The eventual Request for Proposal will be set aside exclusively for small businesses certified under the Small Business Administration 8(a) Program. Due to the need to implement recent FAR Overhaul guidance, the anticipated posting timeframe for the solicitation has been extended to late September 2026. The OMNIBUS IV vehicle operates with a base ordering period from June 20, 2022, through June 19, 2027, and an option ordering period extending to June 19, 2032. It features a cumulative ceiling of 10 billion dollars, with over 630 million dollars already awarded across 55 task orders to various end users, including the Naval Supply Systems Command and the Uniformed Services University of the Health Sciences. New awards from this on-ramp will align with the existing unrestricted vehicle. Prospective offerors must be registered in SAM.gov and will be required to submit proposals through the Procurement Integrated Enterprise Environment solicitation module once the formal RFP is released.

Defense Health Agency

POSTED

about 20 hours ago

DEADLINE

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs Enterprise Procurement Office is initiating an unrestricted procurement under solicitation 36E79727R0039 for Latanoprost Ophthalmic Solution. This acquisition aims to establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The procurement is issued in commercial item format per FAR Part 12 under NAICS code 325412 and is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Strict labeling requirements are in place, requiring offerors to provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the sole label on the product, cannot be affixed over another label, and must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. The solicitation is expected to be issued around October 21, 2026, with a tentative closing date of November 4, 2026, though some metadata indicates a response deadline of October 16, 2026.

Nac Pharmaceuticals (36E797)

POSTED

about 20 hours ago

DEADLINE

Maintenance Services for Medtronic Fusion Stereotactic Neuro Surgical Equipment FY27

Solicitation # 12435632

The Defense Health Agency is soliciting quotes for a firm-fixed price contract to provide preventative and corrective maintenance for Medtronic Fusion stereotactic neuro surgical equipment at the Naval Medical Readiness Training Command Portsmouth in Virginia. This small business set-aside procurement covers a base year from October 22, 2026, to October 21, 2027, with four subsequent one-year option periods. The contractor must be an OEM-certified service provider and authorized dealer, distributor, or reseller, ensuring all maintenance follows manufacturer specifications and utilizes new OEM replacement parts. Key requirements include completing annual preventative maintenance and any necessary repairs by June 15th of each fiscal year, providing written cost estimates for repairs, and supplying software updates at no additional cost. Award will be based on a best value procurement where non-price factors are significantly more important than price. Evaluation factors include technical capability, past performance, and a business summary, with technical capability being the most critical. Quotes must be submitted in four separate volumes by September 29, 2026, and must include a verification statement of current SAM registration. All deliverables are designated as FOB Destination, and the government retains the right to request repairs for latent defects after contract termination.

Defense Health Agency

POSTED

about 20 hours ago

DEADLINE

Supply of Bismuth Subsalicylate SuspensionThis subcontract involves the supply of finished pharmaceutical products to prime contractors supporting DLA Troop Support medical supply contracts. The specific requirement is for the delivery of 2,000 bottles of Bismuth Subsalicylate Suspension, with a strength of 262 MG/15 ML in 240 ML bottles, identified by NSN 6505015056483. All deliverables must strictly adhere to RP001 DLA Packaging Requirements for Procurement. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract is categorized under NAICS code 325412. The designated place of performance is Fort Drum, New York. The solicitation was posted on October 1, 2026, with a response deadline of October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ibuprofen Oral Suspension, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Occlusive Adhesive Dressing SupplierThis subcontract opportunity is for a supplier to provide occlusive adhesive dressings for prime contractors supporting Medical Supply Chain MD SURG FSF projects under the Department of Defense. The selected provider must manufacture or source dressings that strictly adhere to established technical specifications. All units must be packed in sealed containers and commercial exterior shipping containers for transport via common carrier, requiring the supplier to maintain a CAGE code and follow standard commercial packaging guidelines. The project is categorized under NAICS code 325412 and will be performed in Springfield, Missouri. Interested parties must respond by October 7, 2026, to be considered for the delivery of these physical medical supplies.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Albendazole Tablets, USPThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Albendazole Tablets, USP, for prime contractors supporting DLA Troop Support medical supply contracts. The requirement is for 168 bottles of tablets under NSN 6505-01-649-3422, which must meet all USP specifications and be delivered FOB Destination to Fort Bragg. The supplier must maintain FDA registration and ensure the product is packaged in bottles with a non-extendable 24-month shelf life, designated as Type I, Code M. This procurement falls under NAICS code 325412, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Poison Ivy Skin Wash

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Multiple Electrolytes Injection, Type 1

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Loperamide Hydrochloride CapsulesThis subcontract involves the supply of 2,000 bottles of Loperamide Hydrochloride Capsules, each containing 500 capsules of 2mg strength, to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The medication must be pharmaceutical-grade and strictly compliant with NSN 6505012813558, requiring the provider to maintain valid FDA approval and necessary pharmaceutical licensure. Performance of this contract takes place at Fort Bragg and requires strict adherence to DLA packaging requirements RP001 and hazardous materials standards IP025. The procurement falls under NAICS code 325412, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluconazole Tablets 150 MG

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ceftriaxone Sodium in Dextrose InjectionThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Ceftriaxone Sodium in Dextrose Injection to prime contractors for DLA Troop Support medical supply contracts. The requirement is for five packages, each containing 24 plastic bags of 1 gram Ceftriaxone frozen and premixed in an iso-osmotic solution with 1.9 gram dextrose. To ensure product integrity, the contractor must utilize cold-chain storage and transport equipment to maintain a temperature of -20 degrees Celsius per USP standards, with packaging adhering to MIL-STD-2073-1E. The performance location for this contract is FPO 09566-4008, and the response deadline is October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lactated Ringer's Injection, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing (Pentobarbital Sodium)This subcontract involves the manufacture and supply of 20,000 units of pharmaceutical grade Pentobarbital Sodium (NSN 6509-01-485-6206) for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The scope of work encompasses the entire production lifecycle, including chemical synthesis, formulation, and rigorous quality control testing to ensure purity. All materials must be packaged in clean-room facilities using specialized pharmaceutical equipment in accordance with MIL-STD-2073-1E standards. Due to the nature of the substance, the performing entity must maintain active FDA and DEA registrations for handling controlled substances. The project falls under NAICS code 325412 and is designated for performance at APO 96368-5268. Interested parties should note the tight response window following the October 1, 2026, posting date.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Chlorhexidine Prep Swabsticks

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Sodium Chloride 0.9% Injection (USP)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE